A recent study showed that inhibition of the critical transcription factor ZEB2 in ABCs could alleviate lupus pathogenesis, suggesting the therapeutic potential of targeting ABCs in autoimmune disease [30]. This evidence concerns the gene ZEB2 and autoimmune disease.